3 mg Melatonin for Multiple Sclerosis
This trial will explore the effect of melatonin supplementation in subjects with multiple sclerosis who are taking an oral disease modifying therapy. The results of this study could support the rationale for a larger trial to focus on clinical efficacy of melatonin therapy outcomes.
- Multiple Sclerosis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below